Stocks
Grifols, S.A.GRFS
NASDAQHealthcareBiotechnology$7.81-2.01%
A major producer of plasma‑derived medicines used to treat immune deficiencies, neurological disorders, and other chronic conditions, the company operates one of the world’s largest networks of plasma collection centers. Its portfolio includes immunoglobulins, albumin, and transfusion medicine produ...
Market Cap: $6.6B52W Range: $6.19 – $11.14
This page tracks all publicly disclosed congressional trades in Grifols, S.A. (GRFS), a company in the Healthcare sector. 2 members of Congress have disclosed trades in this stock, including 1 purchase and 2 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
3
Unique Politicians
2
Buys
1
Sells
2
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-31 | Daniel Goldman | sell | $1K – $15K |
| 2023-02-27 | Daniel Goldman | buy | $1K – $15K |